Crescent Capital BDC (NASDAQ:CCAP) Sets New 12-Month Low - Time to Sell?

Crescent Capital BDC, Inc. (NASDAQ:CCAP - Get Free Report)'s share price reached a new 52-week low on Monday . The company traded as low as $16.64 and last traded at $17.12, with a volume of 168825 shares changing hands. The stock had previously closed at $17.10.

Wall Street Analysts Forecast Growth

Separately, Wells Fargo & Company lowered their target price on shares of Crescent Capital BDC from $19.00 to $18.00 and set an "equal weight" rating on the stock in a report on Friday, February 21st. One analyst has rated the stock with a hold rating and four have issued a buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average target price of $19.20.

Crescent Capital BDC Stock Performance

The business's fifty day moving average price is $18.40 and its 200-day moving average price is $18.75. The company has a debt-to-equity ratio of 1.18, a current ratio of 1.32 and a quick ratio of 1.26. The stock has a market capitalization of $582.24 million, a PE ratio of 7.89 and a beta of 0.56.

Crescent Capital BDC (NASDAQ:CCAP - Get Free Report) last announced its quarterly earnings results on Wednesday, February 19th. The company reported $0.55 EPS for the quarter, missing the consensus estimate of $0.56 by ($0.01). The firm had revenue of $46.40 million during the quarter, compared to the consensus estimate of $47.27 million. Crescent Capital BDC had a net margin of 37.32% and a return on equity of 11.90%. As a group, equities research analysts expect that Crescent Capital BDC, Inc. will post 2.09 EPS for the current year.

Crescent Capital BDC Dividend Announcement

The firm also recently announced a dividend, which was paid on Friday, March 14th. Shareholders of record on Friday, February 28th were paid a $0.05 dividend. The ex-dividend date of this dividend was Friday, February 28th. Crescent Capital BDC's dividend payout ratio is currently 84.42%.

Institutional Trading of Crescent Capital BDC

A number of large investors have recently modified their holdings of CCAP. Ieq Capital LLC raised its stake in Crescent Capital BDC by 2.6% in the fourth quarter. Ieq Capital LLC now owns 22,725 shares of the company's stock valued at $437,000 after purchasing an additional 584 shares in the last quarter. Confluence Investment Management LLC increased its holdings in shares of Crescent Capital BDC by 0.9% in the 4th quarter. Confluence Investment Management LLC now owns 73,839 shares of the company's stock worth $1,419,000 after buying an additional 633 shares during the last quarter. HighTower Advisors LLC raised its position in shares of Crescent Capital BDC by 0.5% during the 3rd quarter. HighTower Advisors LLC now owns 141,838 shares of the company's stock valued at $2,624,000 after buying an additional 768 shares in the last quarter. Denali Advisors LLC lifted its holdings in shares of Crescent Capital BDC by 0.5% during the 4th quarter. Denali Advisors LLC now owns 183,783 shares of the company's stock worth $3,532,000 after acquiring an additional 855 shares during the last quarter. Finally, Van ECK Associates Corp grew its position in Crescent Capital BDC by 2.3% in the fourth quarter. Van ECK Associates Corp now owns 45,562 shares of the company's stock worth $876,000 after acquiring an additional 1,006 shares in the last quarter. Institutional investors own 49.46% of the company's stock.

About Crescent Capital BDC

Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.